Tissue plasminogen activator with prolonged dwell time effectively evacuates pleural effusions

Area of Science:

• Pulmonology
• Thoracic Surgery
• Critical Care Medicine

Background:

• Complex pleural effusions often require invasive management.
• Current standard fibrinolytic therapy involves tissue plasminogen activator (tPA) and deoxyribonuclease (DNAse) administered twice daily with short dwell times.
• This standard regimen can be logistically complex and medication-intensive.

Purpose of the Study:

• To evaluate the efficacy and safety of a simplified fibrinolytic protocol for complex pleural effusions.
• To compare a daily low-dose tPA regimen with a 12-hour dwell time against the standard twice-daily regimen.
• To assess outcomes including radiographic resolution and need for surgical intervention.

Main Methods:

• A retrospective chart review of patients with complex pleural effusions treated with a simplified tPA protocol.
• The simplified protocol involved daily administration of 4 mg tPA with a 12-hour dwell time, without DNAse.
• Outcomes were assessed based on radiographic findings, chest tube removal time, and need for decortication.

Main Results:

• The study identified 215 effusions in 207 patients, predominantly infectious or malignant (85%).
• A median of 2 doses of tPA was administered per effusion, with 84% requiring three or fewer doses.
• No significant bleeding complications were observed, and 78% of effusions achieved complete drainage, with only 6% requiring decortication.

Conclusions:

• A simplified fibrinolytic regimen of daily low-dose tPA with a 12-hour dwell time appears effective for managing complex pleural effusions.
• This approach requires fewer medication doses and utilizes smaller chest tube catheters compared to the standard regimen.
• The simplified protocol offers a logistically easier and potentially more cost-effective alternative for treating pleural effusions.